FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Hoskins

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Activities & Behaviors

Drug Evaluation

Co-author Network

Publications

TOP 3
Mario Leitao Jr; Douglas A Levine; Kevin Santos; Yukio Sonoda; Abigail Winder; Nadeem R Abu-Rustum; Richard R Barakat; Gabriel Briscoe; Carol L Brown; Dennis S Chi; William J Hoskins; Elizabeth Jewell; Ginger J Gardner
Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach.
Oliver Zivanovic; Camelia S Sima; Alexia Iasonos; William J Hoskins; Pavani R Pingle; Mario Leitao Jr; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat; Dennis S Chi
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.
Dennis S Chi; Pedro T Ramirez; Jerrold B Teitcher; Svetlana Mironov; Debra M Sarasohn; Revathy B Iyer; Eric L Eisenhauer; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Carol L Brown; Carol Aghajanian; David M Gershenson; William J Hoskins; Hedvig Hricak; Richard R Barakat
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Hoskins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mario Leitao Jr; Douglas A Levine; Kevin Santos; Yukio Sonoda; Abigail Winder; Nadeem R Abu-Rustum; Richard R Barakat; Gabriel Briscoe; Carol L Brown; Dennis S Chi; William J Hoskins; Elizabeth Jewell; Ginger J Gardner
Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach.
Gynecologic oncology 2012;125(2):394-9.
2010: Oliver Zivanovic; Camelia S Sima; Alexia Iasonos; William J Hoskins; Pavani R Pingle; Mario Leitao Jr; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat; Dennis S Chi
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.
Gynecologic oncology 2010;116(3):351-7.
2007: Dennis S Chi; Pedro T Ramirez; Jerrold B Teitcher; Svetlana Mironov; Debra M Sarasohn; Revathy B Iyer; Eric L Eisenhauer; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Carol L Brown; Carol Aghajanian; David M Gershenson; William J Hoskins; Hedvig Hricak; Richard R Barakat
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4946-51.
2002: Kaled M. Alektiar; Andrea McKee; Oscar Lin; Venkatraman E Seshan; Michael J Zelefsky; Brady McKee; William J Hoskins; Richard R Barakat
Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
International journal of radiation oncology, biology, physics 2002;54(1):79-85.
2002: Kaled M. Alektiar; Andrea McKee; Oscar Lin; Venkatraman E Seshan; Michael J Zelefsky; Borys Mychalczak; Brady McKee; William J Hoskins; Richard R Barakat
The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Cancer 2002;95(2):316-21.
2002: Kaled M. Alektiar; Andrea McKee; Venkatraman E Seshan; Brady McKee; Michael J Zelefsky; Borys Mychalczak; William J Hoskins; Richard R Barakat
Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
International journal of radiation oncology, biology, physics 2002;53(3):707-13.
2002: Douglas A Levine; William J Hoskins
Update in the management of endometrial cancer.
Cancer journal (Sudbury, Mass.) 2002;8 Suppl 1():S31-40.
2002: Richard R Barakat; Paul Sabbatini; Dharmendra Bhaskaran; Margarita Revzin; Alex Smith; Venkatraman E Seshan; Carol Aghajanian; Martee Hensley; Steven L Soignet; Carol L Brown; Robert A Soslow; Maurie Markman; William J Hoskins; David Spriggs
Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):694-8.
2001: Dennis S Chi; J B Liao; L F Leon; Venkatraman E Seshan; Martee Hensley; Dharmendra Bhaskaran; William J Hoskins
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
Gynecologic oncology 2001;82(3):532-7.
2001: Nadeem R Abu-Rustum; William J Hoskins
Radical abdominal hysterectomy.
The Surgical clinics of North America 2001;81(4):815-28.
2001: Yukio Sonoda; M Zerbe; A Smith; Oscar Lin; Richard R Barakat; William J Hoskins
High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
Gynecologic oncology 2001;80(3):378-82.
2001: Dennis S Chi; WB Jones; Richard R Barakat; K N O'Keefe; William J Hoskins; J L Lewis
The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents.
European journal of gynaecological oncology 2001;22(4):266-8.
2001: Amreen Husain; Dennis S Chi; M Prasad; Nadeem R Abu-Rustum; Richard R Barakat; Carol L Brown; Elizabeth A Poynor; William J Hoskins; JP Curtin
The role of laparoscopy in second-look evaluations for ovarian cancer.
Gynecologic oncology 2001;80(1):44-7.
2000: Richard R Barakat; Teresa A Gilewski; Lois Almadrones; Patricia E Saigo; Venkatraman E Seshan; Clifford Hudis; William J Hoskins
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3459-63.
2000: Amreen Husain; J Curtin; Carol L Brown; Dennis S Chi; William J Hoskins; Elizabeth A Poynor; Kaled M. Alektiar; Richard R Barakat
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.
Gynecologic oncology 2000;78(2):208-11.
2000: Jeff Boyd; Yukio Sonoda; Mark G Federici; Faina Bogomolniy; E Rhei; DL Maresco; Patricia E Saigo; Lois Almadrones; Richard R Barakat; Carol L Brown; Dennis S Chi; JP Curtin; Elizabeth A Poynor; William J Hoskins
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
JAMA : the journal of the American Medical Association 2000;283(17):2260-5.
2000: Dennis S Chi; Venkatraman E Seshan; V Masson; William J Hoskins
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
Gynecologic oncology 2000;77(2):227-31.
1999: Dennis S Chi; Mary L Gemignani; JP Curtin; William J Hoskins
Long-term experience in the surgical management of cancer of the uterine cervix.
Seminars in surgical oncology 1999;17(3):161-7.
1999: Amreen Husain; Paul Sabbatini; David Spriggs; DW Fennelly; Carol Aghajanian; Richard R Barakat; J Curtin; Venkatraman E Seshan; William J Hoskins; Maurie Markman
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.
Gynecologic oncology 1999;73(1):96-101.
1998: Colin B Begg; Laura D Cramer; William J Hoskins; Murray F Brennan
Impact of hospital volume on operative mortality for major cancer surgery.
JAMA : the journal of the American Medical Association 1998;280(20):1747-51.
1998: Carol Aghajanian; DW Fennelly; F Shapiro; RJ Waltzman; Lois Almadrones; Catherine O'Flaherty; K O'Conner; Venkatraman E Seshan; Richard R Barakat; J Curtin; Carol L Brown; Lilian Reich; David Wuest; Larry Norton; William J Hoskins; David Spriggs
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1852-60.
1997: CL Finstad; Kenneth O Lloyd; Mark G Federici; Chaitanya R Divgi; Venkatraman E Seshan; Richard R Barakat; Ronald D Finn; Steven M Larson; William J Hoskins; John L Humm
Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1433-42.
1997: William J Hoskins; L Rice; S Rubin
Ovarian cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines.
Oncology (Williston Park, N.Y.) 1997;11(6):896-900, 903-4.
1997: DW Fennelly; Carol Aghajanian; F Shapiro; Catherine O'Flaherty; K O'Connor; JP Curtin; John Crown; William J Hoskins; David Spriggs
Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer.
Seminars in oncology 1997;24(1 Suppl 2):S2-26-S2-30.
1997: JP Curtin; R Malik; Venkatraman E Seshan; Richard R Barakat; William J Hoskins
Stage IV ovarian cancer: impact of surgical debulking.
Gynecologic oncology 1997;64(1):9-12.
1996: William P McGuire; William J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; K Y Look; Daniel L Clarke-Pearson; M Davidson
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
Seminars in oncology 1996;23(5 Suppl 12):40-7.
1996: Nadeem R Abu-Rustum; Richard R Barakat; P L Siegel; Venkatraman E Seshan; JP Curtin; William J Hoskins
Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy?
Obstetrics and gynecology 1996;88(4 Pt 1):549-53.
1996: E A Stier; Richard R Barakat; JP Curtin; Carol L Brown; W B Jones; William J Hoskins
Laparotomy to complete staging of presumed early ovarian cancer.
Obstetrics and gynecology 1996;87(5 Pt 1):737-40.
1996: JP Curtin; William J Hoskins; Venkatraman E Seshan; Lois Almadrones; K C Podratz; H Long; M Teneriello; H A Averette; B U Sevin
Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial.
Gynecologic oncology 1996;61(1):3-10.
1996: H Gogas; F Shapiro; Carol Aghajanian; DW Fennelly; Lois Almadrones; William J Hoskins; David Spriggs
The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer.
Gynecologic oncology 1996;61(1):22-6.
1996: Maurie Markman; T Hakes; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):796-9.
1996: Beatrice W T Yin; CL Finstad; K Kitamura; Mark G Federici; M Welshinger; V Kudryashov; William J Hoskins; Sydney Welt; Kenneth O Lloyd
Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 1996;65(4):406-12.
1996: William P McGuire; William J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; K Y Look; Daniel L Clarke-Pearson; M Davidson
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
The New England journal of medicine 1996;334(1):1-6.
1995: Tate Thigpen; R B Vance; William P McGuire; William J Hoskins; M Brady
The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience.
Seminars in oncology 1995;22(6 Suppl 14):23-31.
1995: P Francis; eric rowinsky; J Schneider; T Hakes; William J Hoskins; Maurie Markman
Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2961-7.
1995: Richard R Barakat; I Benjamin; J L Lewis; Patricia E Saigo; JP Curtin; William J Hoskins
Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.
Gynecologic oncology 1995;59(3):390-3.
1995: Alice B Kornblith; Howard T Thaler; G Wong; V Vlamis; J M Lepore; D B Loseth; T Hakes; William J Hoskins; Russell Portenoy
Quality of life of women with ovarian cancer.
Gynecologic oncology 1995;59(2):231-42.
1995: JP Curtin; Patricia E Saigo; B Slucher; Venkatraman E Seshan; Borys Mychalczak; William J Hoskins
Soft-tissue sarcoma of the vagina and vulva: a clinicopathologic study.
Obstetrics and gynecology 1995;86(2):269-72.
1995: William P McGuire; William J Hoskins; Mark F Brady; Howard D Homesley; William T Creasman; M L Berman; H Ball; J S Berek; J Woodward
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1589-99.
1995: Maurie Markman; P Francis; eric rowinsky; William J Hoskins
Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer?
Seminars in oncology 1995;22(3 Suppl 6):84-7.
1995: E A Poynor; Richard R Barakat; William J Hoskins
Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Gynecologic oncology 1995;57(2):158-64.
1995: DW Fennelly; J Schneider; David Spriggs; C Bengala; T Hakes; Lilian Reich; Richard R Barakat; J Curtin; Malcolm A S Moore; William J Hoskins
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1160-6.
1995: L Vaccarello; S C Rubin; V Vlamis; G Wong; W B Jones; J L Lewis; William J Hoskins
Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Gynecologic oncology 1995;57(1):61-5.
1994: I Benjamin; Richard R Barakat; JP Curtin; W B Jones; J L Lewis; William J Hoskins
Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related human immunodeficiency virus infection.
Obstetrics and gynecology 1994;84(6):974-8.
1994: William J Hoskins
Epithelial ovarian carcinoma: principles of primary surgery.
Gynecologic oncology 1994;55(3 Pt 2):S91-6.
1994: Richard R Barakat; G Wong; JP Curtin; V Vlamis; William J Hoskins
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features.
Gynecologic oncology 1994;55(2):164-8.
1994: L Vaccarello; V Berghella; S C Rubin; William J Hoskins
Distribution of intraperitoneal chemotherapy into the pleural cavity.
Obstetrics and gynecology 1994;84(4 Pt 2):714-7.
1994: JP Curtin; Richard R Barakat; William J Hoskins
Ovarian disease in women with breast cancer.
Obstetrics and gynecology 1994;84(3):449-52.
1994: Russell Portenoy; Alice B Kornblith; G Wong; V Vlamis; J M Lepore; D B Loseth; T Hakes; Kathleen M Foley; William J Hoskins
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms.
Cancer 1994;74(3):907-15.
1994: William J Hoskins; W P McGuire; Mark F Brady; Howard D Homesley; William T Creasman; M Berman; H Ball; J S Berek
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
American journal of obstetrics and gynecology 1994;170(4):974-9; discussion 979-80.
1994: S C Rubin; CL Finstad; Mark G Federici; L Scheiner; Kenneth O Lloyd; William J Hoskins
Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer.
Cancer 1994;73(5):1456-9.
1994: C Levenback; J Curtin; D Johnston; S C Rubin; S Yeh; William J Hoskins
Image analysis of the distribution of intraperitoneally administered fluids in patients with ovarian cancer.
European journal of gynaecological oncology 1994;15(5):345-51.
1993: S A Davidson; S C Rubin; Borys Mychalczak; Patricia E Saigo; J L Lewis; D Chapman; William J Hoskins
Limited-field radiotherapy as salvage treatment of localized persistent or recurrent epithelial ovarian cancer.
Gynecologic oncology 1993;51(3):349-54.
1993: S C Rubin; L Kostakoglu; Chaitanya R Divgi; Mark G Federici; CL Finstad; Kenneth O Lloyd; Steven M Larson; William J Hoskins
Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer.
Gynecologic oncology 1993;51(1):61-6.
1993: W B Jones; G O Mercer; J L Lewis; S C Rubin; William J Hoskins
Early invasive carcinoma of the cervix.
Gynecologic oncology 1993;51(1):26-32.
1993: S C Rubin; G Y Wong; JP Curtin; Richard R Barakat; T B Hakes; William J Hoskins
Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
Obstetrics and gynecology 1993;82(1):143-7.
1993: S C Rubin; W B Jones; JP Curtin; Richard R Barakat; T B Hakes; William J Hoskins
Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
Obstetrics and gynecology 1993;82(1):139-42.
1993: D M Provencher; CL Finstad; Patricia E Saigo; S C Rubin; William J Hoskins; Mark G Federici; Elisabeth Stockert; Kenneth O Lloyd; J L Lewis
Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer.
Gynecologic oncology 1993;50(1):78-83.
1993: B Reichman; Maurie Markman; T Hakes; S Rubin; W Jones; J Curtin; Richard R Barakat; Lois Almadrones; J L Lewis; William J Hoskins
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinoma.
Gynecologic oncology 1993;50(1):30-3.
1993: Maurie Markman; B Reichman; T Hakes; S Rubin; J L Lewis; W Jones; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
Gynecologic oncology 1993;50(1):100-4.
1993: M Plante; G Y Wong; J S Nisselbaum; Lois Almadrones; William J Hoskins; S C Rubin
Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
Obstetrics and gynecology 1993;81(6):989-92.
1993: Maurie Markman; T Hakes; B Reichman; S Rubin; J Curtin; Richard R Barakat; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatment.
Gynecologic oncology 1993;49(2):185-9.
1993: Maurie Markman; B Reichman; T Hakes; S Rubin; W Jones; J L Lewis; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
The use of recombinant human erythropoietin to prevent carboplatin-induced anemia.
Gynecologic oncology 1993;49(2):172-6.
1993: William J Hoskins
Surgical staging and cytoreductive surgery of epithelial ovarian cancer.
Cancer 1993;71(4 Suppl):1534-40.
1993: Tate Thigpen; Mark F Brady; G A Omura; William T Creasman; William P McGuire; William J Hoskins; S Williams
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience.
Cancer 1993;71(2 Suppl):606-14.
1993: S C Rubin; Kalevi Kairemo; A L Brownell; F Daghighian; Mark G Federici; K S Pentlow; Ronald D Finn; R M Lambrecht; William J Hoskins; J L Lewis
High-resolution positron emission tomography of human ovarian cancer in nude rats using 124I-labeled monoclonal antibodies.
Gynecologic oncology 1993;48(1):61-7.
1992: Maurie Markman; T Hakes; B Reichman; Richard R Barakat; J Curtin; W Jones; J L Lewis; S Rubin; Lois Almadrones; William J Hoskins
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
Seminars in oncology 1992;19(6 Suppl 14):25-7.
1992: Maurie Markman; B Reichman; T Hakes; S Rubin; W Jones; J L Lewis; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.
Gynecologic oncology 1992;47(3):353-7.
1992: William J Hoskins; B N Bundy; J T Thigpen; G A Omura
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 1992;47(2):159-66.
1992: Richard R Barakat; S C Rubin; G Wong; Patricia E Saigo; Maurie Markman; William J Hoskins
Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases.
Obstetrics and gynecology 1992;80(4):660-4.
1992: Richard R Barakat; K Sararian; G Shepherd; M Weinberger; William J Hoskins
Allergy to latex surgical gloves: an unfamiliar cause of intraoperative anaphylaxis.
Gynecologic oncology 1992;46(3):381-3.
1992: Maurie Markman; B Reichman; T Hakes; J L Lewis; W Jones; S Rubin; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1479-84.
1992: S C Rubin; William J Hoskins; Patricia E Saigo; Dattatreyudu Nori; Borys Mychalczak; D Chapman; J L Lewis
Management of endometrial adenocarcinoma with cervical involvement.
Gynecologic oncology 1992;45(3):294-8.
1992: T B Hakes; E Chalas; William J Hoskins; W B Jones; Maurie Markman; S C Rubin; D Chapman; Lois Almadrones; J L Lewis
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma.
Gynecologic oncology 1992;45(3):284-9.
1992: S C Rubin; Mark G Federici; Kenneth O Lloyd; J L Lewis; William J Hoskins
Characterization of a human endometrial carcinoma cell line producing intraperitoneal tumor growth in immunodeficient mice.
Gynecologic oncology 1992;45(3):273-8.
1992: E L Trimble; J L Lewis; L L Williams; JP Curtin; D Chapman; J M Woodruff; S C Rubin; William J Hoskins
Management of vulvar melanoma.
Gynecologic oncology 1992;45(3):254-8.
1992: Charles Levenback; S C Rubin; PM McCormack; William J Hoskins; E Neely Atkinson; J L Lewis
Resection of pulmonary metastases from uterine sarcomas.
Gynecologic oncology 1992;45(2):202-5.
1992: Maurie Markman; T Hakes; B Reichman; J L Lewis; S Rubin; W Jones; Lois Almadrones; F Pizzuto; William J Hoskins
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(2):243-8.
1992: Maurie Markman; W Jones; J L Lewis; S Rubin; T Hakes; B Reichman; Richard R Barakat; J Curtin; Lois Almadrones; William J Hoskins
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.
Journal of cancer research and clinical oncology 1992;118(2):163-5.
1992: Maurie Markman; B Reichman; T Hakes; J Curtin; Richard R Barakat; S Rubin; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy.
Journal of cancer research and clinical oncology 1992;118(5):391-4.
1992: Maurie Markman; B Reichman; T Hakes; Richard R Barakat; J Curtin; S Rubin; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate.
Journal of cancer research and clinical oncology 1992;118(3):235-7.
1992: Maurie Markman; T Hakes; B Reichman; J Curtin; Richard R Barakat; S Rubin; W Jones; J L Lewis; Lois Almadrones; William J Hoskins
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer.
Journal of cancer research and clinical oncology 1992;119(1):55-7.
1991: E L Trimble; Beth Y Karlan; L D Lagasse; William J Hoskins
Diagnosing the correct ovarian cancer syndrome.
Obstetrics and gynecology 1991;78(6):1023-6.
1991: E L Trimble; Patricia E Saigo; G W Freeberg; S C Rubin; William J Hoskins
Peritoneal sarcoidosis and elevated CA 125.
Obstetrics and gynecology 1991;78(5 Pt 2):976-7.
1991: B Reichman; Maurie Markman; T Hakes; A Budnick; S Rubin; W Jones; Lois Almadrones; J L Lewis; William J Hoskins
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy.
Gynecologic oncology 1991;43(2):159-63.
1991: Maurie Markman; B Reichman; T Hakes; W Jones; J L Lewis; S Rubin; Lois Almadrones; William J Hoskins
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1801-5.
1991: Richard R Barakat; S C Rubin; Patricia E Saigo; D Chapman; J L Lewis; W B Jones; T B Hakes; Maurie Markman; B Reichman; William J Hoskins
Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.
Gynecologic oncology 1991;42(2):156-60.
1991: S C Rubin; William J Hoskins; Patricia E Saigo; D Chapman; T B Hakes; Maurie Markman; B Reichman; Lois Almadrones; J L Lewis
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
Gynecologic oncology 1991;42(2):137-41.
1991: Maurie Markman; T Hakes; B Reichman; J L Lewis; S Rubin; W Jones; Lois Almadrones; William J Hoskins
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(6):978-82.
1991: Maurie Markman; R Rothman; T Hakes; B Reichman; J L Lewis; S Rubin; W Jones; Lois Almadrones; William J Hoskins
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinoma.
Gynecologic oncology 1991;41(3):217-9.
1991: William J Hoskins; S C Rubin
Surgery in the treatment of patients with advanced ovarian cancer.
Seminars in oncology 1991;18(3):213-21.
1991: S A Davidson; S C Rubin; Maurie Markman; W B Jones; T B Hakes; B Reichman; Lois Almadrones; D Chapman; J L Lewis; William J Hoskins
Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system.
Gynecologic oncology 1991;41(2):101-6.
1991: Maurie Markman; R Rothman; T Hakes; B Reichman; William J Hoskins; S Rubin; W Jones; Lois Almadrones; J L Lewis
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):389-93.
1991: Maurie Markman; T Hakes; B Reichman; William J Hoskins; S Rubin; W Jones; Lois Almadrones; E L Yordan; J Eriksson; J L Lewis
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(2):204-10.
1991: S C Rubin; CL Finstad; William J Hoskins; D Provencher; Mark G Federici; Kenneth O Lloyd; J L Lewis
Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer.
American journal of obstetrics and gynecology 1991;164(2):558-63.
1991: M Markmann; R Rothman; B Reichman; T Hakes; J L Lewis; S Rubin; W Jones; Lois Almadrones; William J Hoskins
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer.
Journal of cancer research and clinical oncology 1991;117(2):89-90.
1991: JP Curtin; William J Hoskins; S C Rubin; W B Jones; T B Hakes; Maurie Markman; B Reichman; Lois Almadrones; J L Lewis
Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy.
Gynecologic oncology 1991;40(1):17-20.
1990: JP Curtin; S C Rubin; W B Jones; William J Hoskins; J L Lewis
Paget's disease of the vulva.
Gynecologic oncology 1990;39(3):374-7.
1990: CL Finstad; Patricia E Saigo; S C Rubin; Mark G Federici; D M Provencher; William J Hoskins; J L Lewis; Kenneth O Lloyd
Immunohistochemical localization of P-glycoprotein in adult human ovary and female genital tract of patients with benign gynecological conditions.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1990;38(11):1677-81.
1990: L W Ng; S C Rubin; William J Hoskins; W B Jones; T B Hakes; Maurie Markman; B Reichman; Lois Almadrones; J L Lewis
Aggressive chemosurgical debulking in patients with advanced ovarian cancer.
Gynecologic oncology 1990;38(3):358-63.
1990: S C Rubin; CL Finstad; William J Hoskins; Patricia E Saigo; D M Provencher; Mark G Federici; T B Hakes; Maurie Markman; B S Reichman; Kenneth O Lloyd
Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistance.
American journal of obstetrics and gynecology 1990;163(1 Pt 1):69-73.
1990: Maurie Markman; M George; T Hakes; B Reichman; William J Hoskins; S Rubin; W Jones; Lois Almadrones; J L Lewis
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):146-50.
1990: Andrew Berchuck; S C Rubin; William J Hoskins; Patricia E Saigo; V K Pierce; J L Lewis
Treatment of endometrial stromal tumors.
Gynecologic oncology 1990;36(1):60-5.
1989: William J Hoskins
Surgical procedures in gynecologic oncology.
Current opinion in oncology 1989;1(1):89-96.
1989: H J Buchsbaum; Mark F Brady; G Delgado; A Miller; William J Hoskins; A Manetta; G Sutton
Surgical staging of carcinoma of the ovaries.
Surgery, gynecology & obstetrics 1989;169(3):226-32.
1989: S C Rubin; CL Finstad; William J Hoskins; Mark G Federici; Kenneth O Lloyd; J L Lewis
A longitudinal study of antigen expression in epithelial ovarian cancer.
Gynecologic oncology 1989;34(3):389-94.
1989: B Reichman; Maurie Markman; T Hakes; William J Hoskins; S Rubin; W Jones; Lois Almadrones; M Ochoa; D Chapman; Patricia E Saigo
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1327-32.
1989: William J Hoskins; S C Rubin; E Dulaney; D Chapman; Lois Almadrones; Patricia E Saigo; Maurie Markman; T Hakes; B Reichman; W B Jones
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.
Gynecologic oncology 1989;34(3):365-71.
1989: S C Rubin; William J Hoskins; Maurie Markman; Mark G Federici; Kenneth O Lloyd; J L Lewis
Synergistic activity of tumor necrosis factor and interferon in a nude mouse model of human ovarian cancer.
Gynecologic oncology 1989;34(3):353-6.
1989: S C Rubin; I Benjamin; William J Hoskins; V K Pierce; J L Lewis
Intestinal surgery in gynecologic oncology.
Gynecologic oncology 1989;34(1):30-3.
1989: Maurie Markman; T Hakes; B Reichman; William J Hoskins; S Rubin; W Jones; L Almadones; J L Lewis
Intraperitoneal therapy in the management of ovarian carcinoma.
The Yale journal of biology and medicine 1989;62(4):393-403.
1989: S C Rubin; William J Hoskins; I Benjamin; J L Lewis
Palliative surgery for intestinal obstruction in advanced ovarian cancer.
Gynecologic oncology 1989;34(1):16-9.
1989: JP Curtin; S C Rubin; William J Hoskins; T B Hakes; J L Lewis
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Obstetrics and gynecology 1989;73(5 Pt 2):893-5.
1989: S C Rubin; William J Hoskins; Maurie Markman; T Hakes; J L Lewis
Long-term access to the peritoneal cavity in ovarian cancer patients.
Gynecologic oncology 1989;33(1):46-8.
1989: A F Fuller; N Elliott; C Kosloff; William J Hoskins; J L Lewis
Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix.
Gynecologic oncology 1989;33(1):34-9.
1989: M G Fort; V K Pierce; Patricia E Saigo; William J Hoskins; J L Lewis
Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential.
Gynecologic oncology 1989;32(3):269-72.
1989: S C Rubin; William J Hoskins; T B Hakes; Maurie Markman; B S Reichman; D Chapman; J L Lewis
Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
American journal of obstetrics and gynecology 1989;160(3):667-71.
1989: Maurie Markman; B Reichman; T Hakes; William J Hoskins; S Rubin; W Jones; J L Lewis
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).
Acta medica Austriaca 1989;16(3-4):65-7.
1988: S C Rubin; William J Hoskins; T B Hakes; Maurie Markman; J M Cain; J L Lewis
Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
American journal of obstetrics and gynecology 1988;159(5):1094-8.
1988: S C Rubin; E D Dulaney; Maurie Markman; William J Hoskins; Patricia E Saigo; J L Lewis
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
Obstetrics and gynecology 1988;71(6 Pt 1):851-3.
1988: Andrew Berchuck; S C Rubin; William J Hoskins; Patricia E Saigo; V K Pierce; J L Lewis
Treatment of uterine leiomyosarcoma.
Obstetrics and gynecology 1988;71(6 Pt 1):845-50.
1988: R D'Acquisto; Maurie Markman; T Hakes; S Rubin; William J Hoskins; J L Lewis
A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):689-95.
1988: B Reichman; Maurie Markman; T Hakes; Nancy Kemeny; David P Kelsen; William J Hoskins; S Rubin; J L Lewis
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(1):158-62.